| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | WO2003020884A3 Method for rapid generation of mature dendritic cells |
| 09/16/2004 | WO2002100827A3 Method for increasing the survival of dopamine secreting cells |
| 09/16/2004 | WO2002094198A9 Modulation of cell division by an early mitotic inhibitor protein |
| 09/16/2004 | US20040181827 Plant Gntl sequences and the use thereof for the production of plants having reduced or lacking N-acetyl glucosaminyl transferase I (GnTI) activity |
| 09/16/2004 | US20040181826 for for producing flavonoids using transgenic plants transformed by a genetically engineered vector |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040181044 for bone marrow recovery in treatment of radiation, chemical, or chemotherapeutic induced bone marrow aplasia or myelosuppression |
| 09/16/2004 | US20040181037 Phosphatidyl serine receptors and uses thereof |
| 09/16/2004 | US20040181036 Mutant forms of cholera holotoxin as an adjuvant |
| 09/16/2004 | US20040181034 Multimeric Apo A-I agonist compounds |
| 09/16/2004 | US20040181032 for promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 09/16/2004 | US20040180826 Novel receptor that causes cell death |
| 09/16/2004 | US20040180441 Preparing immortalized cell line which produces adipocytes in nutrient broth containing vitamin d3, k and dexamethasome |
| 09/16/2004 | US20040180437 Optoinjection methods |
| 09/16/2004 | US20040180435 Process for producing a substrate for attachment of cells and a substrate for attachment of cells |
| 09/16/2004 | US20040180434 Materials and methods for nerve grafting, selection of nerve grafts, and in vitro nerve tissue culture |
| 09/16/2004 | US20040180432 Propagating human hematopoietic cells in culture via inoculation of bioreactor nutrient broth with transgenic stromal cells expressing growth factor proteins and perfusion of progenitor cells with medium with subsequent recovery of hematopoietic tissue |
| 09/16/2004 | US20040180431 Preparing three-dimensional biological scaffolding for use in soft tissue augmentation; tissue engineering and repair of skin defects |
| 09/16/2004 | US20040180430 Using nuclear transplantation of primary cell, nucleus from primary cell or chromosomes from primary cell to regenerate chromsome ends of near senescent cells; tissue engineering and organ replacement therapy; telomerase activation |
| 09/16/2004 | US20040180429 Spliceosome mediated RNA trans-splicing in stem cells |
| 09/16/2004 | US20040180428 Automated apparatus for injecting sample of gene, pigment, protein, peptide or drug into oocytes of frogs using pipette-like needle; tissue engineering |
| 09/16/2004 | US20040180422 Generating phage particles comprising heterologous coat proteins for use as tools in screening and identifying preferential protein ligands; drug screening |
| 09/16/2004 | US20040180418 Candida kefyr cytosine deaminase |
| 09/16/2004 | US20040180407 Novel G protein coupled receptor protein, DNA and its ligand |
| 09/16/2004 | US20040180395 Method for detecting calpain3 activity in a biological sample and peptides for implementing said method |
| 09/16/2004 | US20040180356 Comprises nucleotide sequences coding membrane proteins for use in diagnosis, prevention and treatment of cell proliferative, metabolic and inflammatory disorders |
| 09/16/2004 | US20040180354 Comprises polypeptides which are displayable on antigen presenting cells of immune system for use in prevention and treatment of infection and vaccine development; immunotherapy |
| 09/16/2004 | US20040180351 Interfering RNA molecules |
| 09/16/2004 | US20040180348 Method for surface display of proteins of genetic carriers |
| 09/16/2004 | US20040180338 Mutated eukariotic transalation initiation factor 2 alpha kinase3, eif2ak3, in patients with neonatal insuluin-dependant diabetes and multiple epiphyseal dyslapsia (wolcott-rallison syndrome) |
| 09/16/2004 | US20040180337 Human extracellular signal regulated kinases |
| 09/16/2004 | US20040180333 Self-replicating RNA molecule from hepatitis C virus |
| 09/16/2004 | US20040180321 comprising red blood cells; for treating in vitro/ex vivo using a non-radical cationic group |
| 09/16/2004 | US20040180052 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 09/16/2004 | US20040180048 Administering to a subject in need thereof an effective amount of an isolated molecule comprising an antibody variable region which specifically binds to a neuronal marker (NM) protein |
| 09/16/2004 | US20040180046 Bispecific molecules and uses thereof |
| 09/16/2004 | US20040180043 Administering stem cell products to a heart in need of treatment, whereby the stem cells products increase cardiac function thereby treating heart failure and improving cardiac function |
| 09/16/2004 | US20040180042 Graft prosthesis, materials and methods |
| 09/16/2004 | US20040180041 Administering to or transplanting into patient at least one cell or tissue obtained from a cloned ungulate animal or embryo |
| 09/16/2004 | CA2787818A1 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 09/16/2004 | CA2517982A1 Cell culture |
| 09/16/2004 | CA2517968A1 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 09/16/2004 | CA2517959A1 Expansion of renewable stem cell populations using modulators of pi 3-kinase |
| 09/16/2004 | CA2517916A1 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
| 09/16/2004 | CA2517525A1 Posh interacting proteins and related methods |
| 09/16/2004 | CA2517327A1 Animal-free cell culture method |
| 09/16/2004 | CA2517287A1 Regulation of t cells by lag-3 (cd223) |
| 09/16/2004 | CA2517145A1 Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 09/16/2004 | CA2517097A1 Identification of antigen epitopes |
| 09/16/2004 | CA2516519A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/15/2004 | EP1457571A1 Reporter gene assay method |
| 09/15/2004 | EP1457552A1 Carrier for tissue- and cell-culture for the preparation of implants and implant containing the carrier |
| 09/15/2004 | EP1457500A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalophathies |
| 09/15/2004 | EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor |
| 09/15/2004 | EP1456650A2 Gfats as modifiers of the p53 pathway and methods of use |
| 09/15/2004 | EP1456419A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 09/15/2004 | EP1456400A2 Modulating insulin receptor signaling through targeting facl |
| 09/15/2004 | EP1456396A1 Hybrid glycosylated products and their production and use |
| 09/15/2004 | EP1456386A2 Polycistronic expression of antibodies |
| 09/15/2004 | EP1456385A2 Growth hormone fusion protein |
| 09/15/2004 | EP1456384A2 Novel alkaline protease from bacillus sp. (dsm 14390) and washing and cleaning products comprising said novel alkaline protease |
| 09/15/2004 | EP1456383A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 09/15/2004 | EP1456382A2 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456374A2 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| 09/15/2004 | EP1456373A2 Seminal vesicle tissue-specific promoters and uses thereof |
| 09/15/2004 | EP1456372A2 Emission ratiometric indicators of phosphorylation |
| 09/15/2004 | EP1456368A2 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
| 09/15/2004 | EP1456367A1 Novel alkaline protease from bacillus gibsonii (dsm 14391) and washing and cleaning agents containing said novel alkaline protease |
| 09/15/2004 | EP1456366A1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 09/15/2004 | EP1456365A2 Protein modification and maintenance molecules |
| 09/15/2004 | EP1456360A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs |
| 09/15/2004 | EP1456358A2 Cultured stromal cells and uses thereof |
| 09/15/2004 | EP1456357A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 09/15/2004 | EP1456356A2 Method of producing human beta cell lines |
| 09/15/2004 | EP1456355A2 Process for the manufacture of human mononuclear phagocytic leukocytes |
| 09/15/2004 | EP1456354A2 Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof |
| 09/15/2004 | EP1456353A2 The use of acyl salicylates as heat shock inducers |
| 09/15/2004 | EP1456352A1 Solid culture medium for micro-organisms and eukaryotic cells and the production method of same |
| 09/15/2004 | EP1456347A2 Antibodies that immunospecifically bind to blys |
| 09/15/2004 | EP1456346A2 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system |
| 09/15/2004 | EP1456246A1 Chitosan-thio-amidine conjugates and their cosmetic as well as pharmaceutic use |
| 09/15/2004 | EP1456239A2 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 09/15/2004 | EP1456238A2 Production of f(ab')2 fragments in mammalian cells |
| 09/15/2004 | EP1456235A2 Factor viii c2 domain variants |
| 09/15/2004 | EP1456230A2 Flavivirus ns1 subunit vaccine |
| 09/15/2004 | EP1456228A2 Method of isolation and purification of trypsin from pronase and use thereof |
| 09/15/2004 | EP1456223A2 Rapidly maturing fluorescent proteins and methods for using the same |
| 09/15/2004 | EP1456222A2 Non-human primate fc receptors and methods of use |
| 09/15/2004 | EP1456221A2 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 09/15/2004 | EP1456220A2 Thermus thermophilus nucleic acid polymerases |
| 09/15/2004 | EP1456130A1 Forming and modifying dielctrically-engineered microparticles |
| 09/15/2004 | EP1455854A1 Skin/hair equivalent with reconstructed papillae |
| 09/15/2004 | EP1455815A2 Human diacylglycerol acyltransferase 2 (dgat2)family members and uses therefor |
| 09/15/2004 | EP1455670A2 Optical cell guidance method and apparatus |
| 09/15/2004 | EP1414944A4 Methods for ex vivo propagation of somatic stem cells |
| 09/15/2004 | EP1294855A4 Method of controlling differentiation of embryonic stem (es) cells by culturing es cells in the presence of bmp-2 pathway antagonists |
| 09/15/2004 | EP1284756B1 Shape memory thermoplastics and polymer networks for tissue engineering |
| 09/15/2004 | EP1123111B1 Modulation of dna methyltransferase expression by combination therapy |